Seamon KB, Daly JW. Forskolin: a unique diterpene activator of cAMP-generating systems.
J Cyclic Nucleotide Res. 1981;7:201-224.
Laurenza A, Sutkowski EM, Seamon KB. Forskolin: a specific stimulator of adenylyl cyclase or a diterpene with multiple sites of action?
Trends Pharmacol Sci. 1989;10:442-447.
Marone G, Columbo M, Triggiani S, et al. Forskolin inhibits the release of histamine from human basophils and mast cells.
Agents Actions. 1986;18:96-99.
Ammon HPT, Muller AB. Forskolin: from an Ayurvedic remedy to a modern agent.
Planta Med. 1985:473-477.
DeSouza NJ. Industrial development of traditional drugs: the forskolin example. A mini-review.
J Ethnopharmacol. 1993;38:177-180.
Kreutner W, Chapman RW, Gulbenkian A, et al. Bronchodilatory and antiallergy activity of forskolin.
Eur J Pharmacol. 1985;111:1-8.
Schlepper M, Thormann J, Mitrovic V. Cardiovascular effects of forskolin and phosphodiesterase-III inhibitors.
Basic Res Cardiol.
1989;84(suppl 1):197-212.
Dubey MP, Srimal RC, Nityanand S, et al. Pharmacological studies on coleonol, a hypotensive diterpene from
Coleus forskohlii. J Ethnopharmacol. 1981;3:1-13.
Yousif MH, Thulesius O. Forskolin reverses tachyphylaxis to the bronchodilator effects of salbutamol: an in-vitro study on isolated guinea-pig trachea.
J Pharm Pharmacol.
1999;51:181-186.
Bauer K, Dietersdorfer F, Sertl K, et al. Pharmacodynamic effects of inhaled dry powder formulations of fenoterol and colforsin in asthma.
Clin Pharmacol Ther. 1993;53:76-83.
Meyer BH, Stulting AA, Muller FO, et al. The effects of forskolin eye drops on intraocular pressure.
S Afr Med J. 1987;71:570-571.
Godard MP, Johnson BA, Richmond SR, et al. Body composition and hormonal adaptations associated with forskolin consumption in overweight and obese men.
Obes Res. 2005;13:1335-1343.
Contaminated Coleus forskohlii products cause adverse reactions in Italy. Available at:
http://www.nutraingredients.com/news/ng.asp?n=60364m=1nie6...=tbtcgrwexqoosjy. Accessed January 6, 2005.
Gonzalez-Sanchez R, Trujillo X, Trujillo-Hernandez B et al. Forskolin versus sodium cromoglycate for prevention of asthma attacks: a single-blinded clinical trial.
J Int Med Res.
2006;34:200-207.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.